Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Surgical Removal of Primary Tumors in Stage IV MBC

June 9th 2013

Managing Bone Health in Metastatic Breast Cancer

June 9th 2013

Case Study: Treating HR+ and HER2- Breast Cancer

June 9th 2013

Paclitaxel With Pertuzumab Plus Trastuzumab in MBC

June 9th 2013

Case Study: Treating HER2-Positive MBC, Part II

June 9th 2013

Case Study: Treating HER2-Positive MBC, Part I

June 9th 2013

Treatment With Eribulin in Metastatic Breast Cancer

June 9th 2013

MA.31 Trial: Taxane With Lapatinib or Trastuzumab

June 9th 2013

CLEOPATRA Trial: Frontline Pertuzumab for HER2+ MBC

June 9th 2013

Frontline T-DM1 in HER2+ Metastatic Breast Cancer

June 9th 2013

EMILIA Trial: T-DM1 in Metastatic Breast Cancer

June 9th 2013

Management of mTOR Inhibitor Side Effects in Breast Cancer

June 9th 2013

BOLERO-2 Trial: Everolimus in Metastatic Breast Cancer

June 9th 2013

Combination of Anastrozole and Fulvestrant in MBC

June 9th 2013

Introduction and Exploration of Fulvestrant in Breast Cancer

June 9th 2013

Dr. Rutgers Compares ART or ALND in Breast Cancer

June 7th 2013

Emiel J. Rutgers, MD, surgical oncologist, Netherlands Cancer Institute, Amsterdam, discusses a study analyzing radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients.

Dr. Finn on the Future of Palbociclib in Breast Cancer

June 6th 2013

Richard Finn, MD, from the Jonsson Comprehensive Cancer Center, describes the potential impact of the cyclin-dependent kinase 4/6 inhibitor palbociclib (PD-0332991) in the treatment of patients with ER-positive metastatic breast cancer.

Axillary Radiotherapy Equal to Surgery in Early Breast Cancer

June 6th 2013

Women with early sentinel lymph node-positive breast cancer achieve as much of a disease-free and survival benefit from axillary radiotherapy as they do from axillary lymph node dissection with significantly less risk of lymphedema.

Dr. Churpek on Gene Mutations in Breast Cancer

June 6th 2013

Jane E. Churpek, MD, discusses a study that found the inherited mutations in breast cancer genes in African American breast cancer patients were revealed by targeted genomic capture and next-generation sequencing.

Revisiting HER2: Recent Research Shakes Views on Famed Marker

June 5th 2013

New research suggests that HER2-targeted drugs may actually have much broader applications, benefiting patients who are not designated HER2-positive by routine testing.